BioCryst Pharmaceuticals Inc. (BCRX) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $8.60, BioCryst Pharmaceuticals Inc. dropped to $7.63 for a new 52-week low. By the closing bell, the company's stock was at $7.65 a share for a loss of 10%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal.
Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their
shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

BioCryst Pharmaceuticals Inc. saw 621,013 shares of its stock trade hands, that's out of 73.34 million shares outstand. The stock has an average daily
volume of 859,935 shares. After hitting a new 52-week low, BioCryst Pharmaceuticals Inc. enters the new trading day with a market cap of 561.03 million, a 50-day SMA of $10.00 and a 200-day SMA of $11.44

Biocryst Pharmaceuticals Inc is a biotechnology company. The Company designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases.

BioCryst Pharmaceuticals Inc. has 50 employees, is led by CEO Jon P. Stonehouse, and makes its home in Durham, NC.

BioCryst Pharmaceuticals Inc. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer